Adipose tissue modulation of HDL

Bibliography

• Gordon DJ, Rifkind BM: High-density lipoprotein – the clinical implications of recent studies. N. Engl. J. Med. 321(19), 1311–1316 (1989).
   Google Scholar
• Miller GJ, Miller NE: Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1(7897), 16–19 (1975).
   Google Scholar
• Rader DJ: Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 92(4A), 42J-49J (2003).
   Google Scholar
• Robinson JG: Low high-density lipoprotein cholesterol and chronic disease risk marker or causal? J. Am. Coll. Cardiol. 55(25), 2855–2857 (2010).
   Google Scholar
• Laszlo A, Simon M: Serum lipid and lipoprotein levels in premature ageing syndromes: total lipodystrophy and Cockayne syndrome. Arch. Gerontol. Geriatr. 5(3), 189–196 (1986).
   Google Scholar
• Simha V, Garg A: Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia. J. Clin. Endocrinol. Metab. 87(2), 776–785 (2002).
   Google Scholar
• Howard BV, Ruotolo G, Robbins DC: Obesity and dyslipidemia. Endocrinol. Metab. Clin. North Am. 32(4), 855–867 (2003).
   Google Scholar
• Rader DJ: Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am. J. Med. 120(3 Suppl. 1), S12-S18 (2007).
   Google Scholar
• Ginsberg HN, Zhang YL, Hernandez-Ono A: Metabolic syndrome: focus on dyslipidemia. Obesity 14(Suppl. 1), 41S-49S (2006).
   Google Scholar
• Bays HE, González-Campoy JM, Bray GA et al.: Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev. Cardiovasc. Ther. 6(3), 343–368 (2008).
   Google Scholar
• Grundy SM: Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 95(1), 1–4 (1997).
   Google Scholar
• Frayn KN: Adipose tissue as a buffer for daily lipid flux. Diabetologia 45(9), 1201–1210 (2002).
   Google Scholar
• Carneheim CM, Alexson SE: Refeeding and insulin increase lipoprotein lipase activity in rat brown adipose tissue. Am. J. Physiol. 256(5 Pt 1), E645-E650 (1989).
   Google Scholar
• Meijssen S, Cabezas MC, Ballieux CG, Derksen RJ, Bilecen S, Erkelens DW: Insulin mediated inhibition of hormone sensitive lipase activity in vivo in relation to endogenous catecholamines in healthy subjects. J. Clin. Endocrinol. Metab. 86(9), 4193–4197 (2001).
   Google Scholar
• Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J. Clin. Invest. 116(7), 1793–1801 (2006).
   Google Scholar
• Guilherme A, Virbasius JV, Puri V, Czech MP: Adipocyte dysfunctions linking obesity to insulin resistance and Type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9(5), 367–377 (2008).
   Google Scholar
• Ong JM, Kern PA: Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. J. Clin. Invest. 84(1), 305–311 (1989).
   Google Scholar
• Bradbury MW: Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 290(2), G194-G198 (2006).
   Google Scholar
• Nicklas BJ, Rogus EM, Colman EG, Goldberg AP: Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women. Am. J. Physiol. 270(1 Pt 1), E72-E78 (1996).
   Google Scholar
• Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S: Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134(2), 424–431 (2008).
   Google Scholar
• Chan DC, Watts GF, Gan S, Wong AT, Ooi EM, Barrett PH; Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity. Arterioscler. Thromb. Vasc. Biol. 30(5), 1043–1050 (2010).
   Google Scholar
• Rader DJ: Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein. Curr. Atheroscler. Rep. 6(5), 398–405 (2004).
   Google Scholar
• Asayama K, Hayashibe H, Dobashi K et al.: Increased serum cholesteryl ester transfer protein in obese children. Obes. Res. 10(6), 439–446 (2002).
   Google Scholar
• Park KH, Shin DG, Kim JR, Hong JH, Cho KH; The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity. Int. J. Mol. Med. 25(1), 129–136 (2010).
   Google Scholar
• Le Goff W, Guerin M, Chapman MJ: Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Pharmacol. Ther. 101(1), 17–38 (2004).
   Google Scholar
• Badellino KO, Wolfe ML, Reilly MP, Rader DJ: Endothelial lipase is increased in vivo by inflammation in humans. Circulation 117(5), 678–685 (2008).
   Google Scholar
• Paradis ME, Badellino KO, Rader DJ et al.: Visceral adiposity and endothelial lipase. J. Clin. Endocrinol. Metab. 91(9), 3538–3543 (2006).
   Google Scholar
• Rashid S, Barrett PH, Uffelman KD, Watanabe T, Adeli K, Lewis GF: Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation. Arterioscler. Thromb. Vasc. Biol. 22(3), 483–487 (2002).
   Google Scholar
• Rader DJ: Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 116(12), 3090–3100 (2006).
   Google Scholar
• Timmins JM, Lee JY, Boudyguina E et al.: Targeted inactivation of hepatic ABCA1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoAI. J. Clin. Invest. 115(5), 1333–1342 (2005).
   Google Scholar
• Lee JY, Timmins JM, Mulya A et al.: HDLs in apoAI transgenic ABCA1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney. J. Lipid Res. 46(10), 2233–2245 (2005).
   Google Scholar
• Kiss RS, McManus DC, Franklin V et al.: The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways. J. Biol. Chem. 278(12), 10119–10127 (2003).
   Google Scholar
• Dietschy JM, Turley SD: Control of cholesterol turnover in the mouse. J. Biol. Chem. 277(6), 3801–3804 (2002).
   Google Scholar
• Adorni MP, Zimetti F, Billheimer JT et al.: The roles of different pathways in the release of cholesterol from macrophages. J. Lipid Res. 48(11), 2453–2462 (2007).
   Google Scholar
• Haghpassand M, Bourassa PA, Francone OL, Aiello RJ: Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108(9), 1315–1320 (2001).
   Google Scholar
• Karasinska JM, Rinninger F, Lütjohann D et al.: Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J. Neurosci. 29(11), 3579–3589 (2009).
   Google Scholar
• Brunham LR, Kruit JK, Iqbal J et al.: Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116(4), 1052–1062 (2006).
   Google Scholar
• Yvan-Charvet L, Bobard A, Bossard P et al.: In vivo evidence for a role of adipose tissue SR-BI in the nutritional and hormonal regulation of adiposity and cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 27(6), 1340–1345 (2007).
   Google Scholar
• Krause BR, Hartman AD: Adipose tissue and cholesterol metabolism. J. Lipid Res. 25(2), 97–110 (1984).
   Google Scholar
• Angel A, Yuen R, Nettleton JA: Exchange of free cholesterol between low density lipoproteins and human adipocytes. Can. J. Biochem. 59(8), 655–661 (1981).
   Google Scholar
• Prattes S, Horl G, Hammer A et al.: Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures. J. Cell. Sci. 113(Pt 17), 2977–2989 (2000).
   Google Scholar
• Le Lay S, Robichon C, Le Liepvre X, Dagher G, Ferre P, Dugail I: Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells. J. Lipid Res. 44(8), 1499–1507 (2003).
   Google Scholar
• Zhao SP, Dong SZ: Effect of tumor necrosis factor alpha on cholesterol efflux in adipocytes. Clin. Chim. Acta 389(1–2), 67–71 (2008).
   Google Scholar
• Zhao SP, Wu ZH, Hong SC, Ye HJ, Wu J: Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. Clin. Chim. Acta 365(1–2), 119–124 (2006).
   Google Scholar
• Zhang Y, McGillicuddy FC, Hinkle CC et al.: Adipocyte modulation of high-density lipoprotein cholesterol. Circulation 121(11), 1347–1355 (2010).
   Google Scholar
• Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J. Clin. Invest. 115(5), 1111–1119 (2005).
   Google Scholar
• Nishimura S, Manabe I, Nagasaki M et al.: CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15(8), 914–920 (2009).
   Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112(12), 1796–1808 (2003).
   Google Scholar
• Chung S, LaPoint K, Martinez K, Kennedy A, Sandberg MB, McIntosh MK: Preadipocytes mediate lipopolysaccharide- induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147(11), 5340–5351 (2006).
   Google Scholar
• McGillicuddy FC, de la Llera Moya M, Hinkle CC etal.: Inflammation impairs reverse cholesterol transport in vivo. Circulation 119(8), 1135–1145 (2009).
   Google Scholar
• Undurti A, Huang Y, Lupica JA, Smith JD, DiDonato JA, Hazen SL: Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J. Biol. Chem. 284(45), 30825–30835 (2009).
   Google Scholar
• Khovidhunkit W, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C: Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase. J. Lipid Res. 42(6), 967–975 (2001).
   Google Scholar
• Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J. Clin. Endocrinol. Metab. 87(6), 2764–2769 (2002).
   Google Scholar